972 related articles for article (PubMed ID: 26130094)
21. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
Hilkens NA; Algra A; Greving JP
Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618
[TBL] [Abstract][Full Text] [Related]
22. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
23. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
[TBL] [Abstract][Full Text] [Related]
24. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
[TBL] [Abstract][Full Text] [Related]
25. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.
RAF and RENO-EXTEND Investigators*
Eur Stroke J; 2023 Sep; 8(3):722-730. PubMed ID: 37458099
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study.
Yaghi S; Mistry E; Liberman AL; Giles J; Asad SD; Liu A; Nagy M; Kaushal A; Azher I; Mac Grory B; Fakhri H; Brown Espaillat K; Pasupuleti H; Martin H; Tan J; Veerasamy M; Esenwa C; Cheng N; Moncrieffe K; Moeini-Naghani I; Siddu M; Scher E; Trivedi T; Lord A; Furie K; Keyrouz S; Nouh A; Leon Guerrero CR; de Havenon A; Khan M; Henninger N
Stroke; 2020 Sep; 51(9):2724-2732. PubMed ID: 32757753
[TBL] [Abstract][Full Text] [Related]
27. Non-vitamin K oral anticoagulants as first-line regimen for acute ischemic stroke with non-valvular atrial fibrillation.
Park CW; Nam HS; Heo JH; Park HJ; Choi JK; Lee HS; Na HK; Kim YD
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105025. PubMed ID: 32807440
[TBL] [Abstract][Full Text] [Related]
28. Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.
Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Panigada G; Spolveri S; Landini G
J Thromb Thrombolysis; 2019 Feb; 47(2):292-300. PubMed ID: 30470967
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation.
Yaghi S; Liberman AL; Henninger N; Grory BM; Nouh A; Scher E; Giles J; Liu A; Nagy M; Kaushal A; Azher I; Fakhri H; Espaillat KB; Asad SD; Pasupuleti H; Martin H; Tan J; Veerasamy M; Esenwa C; Cheng N; Moncrieffe K; Moeini-Naghani I; Siddu M; Trivedi T; Ishida K; Frontera J; Lord A; Furie K; Keyrouz S; de Havenon A; Mistry E; Leon Guerrero CR; Khan M
J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104888. PubMed ID: 32414583
[TBL] [Abstract][Full Text] [Related]
30. Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation.
Mizoguchi T; Tanaka K; Toyoda K; Yoshimura S; Itabashi R; Takagi M; Todo K; Shiozawa M; Yagita Y; Yoshimoto T; Terasaki T; Yamagami H; Takizawa S; Inoue M; Kamiyama K; Ihara M; Okada Y; Kitazono T; Koga M;
Stroke; 2020 Mar; 51(3):883-891. PubMed ID: 31964290
[TBL] [Abstract][Full Text] [Related]
31. Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study.
Yasaka M; Umeyama M; Kataoka H; Inoue H
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105034. PubMed ID: 32807446
[TBL] [Abstract][Full Text] [Related]
32. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
Best JG; Arram L; Ahmed N; Balogun M; Bennett K; Bordea E; Campos MG; Caverly E; Chau M; Cohen H; Dehbi HM; Doré CJ; Engelter ST; Fenner R; Freemantle N; Hunter R; James M; Lip GY; Murray ML; Norrving B; Sprigg N; Veltkamp R; Zaczyk I; Werring DJ;
Int J Stroke; 2022 Jun; 17(5):583-589. PubMed ID: 35018878
[TBL] [Abstract][Full Text] [Related]
33. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
Wilson D; Ambler G; Shakeshaft C; Brown MM; Charidimou A; Al-Shahi Salman R; Lip GYH; Cohen H; Banerjee G; Houlden H; White MJ; Yousry TA; Harkness K; Flossmann E; Smyth N; Shaw LJ; Warburton E; Muir KW; Jäger HR; Werring DJ;
Lancet Neurol; 2018 Jun; 17(6):539-547. PubMed ID: 29778365
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation - A Nationwide Cohort Study.
Jung H; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Sung JH; Pak HN; Lee MH; Lip GYH; Joung B
Circ J; 2019 Nov; 83(12):2547-2554. PubMed ID: 31619594
[TBL] [Abstract][Full Text] [Related]
35. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk.
Yaghi S; Trivedi T; Henninger N; Giles J; Liu A; Nagy M; Kaushal A; Azher I; Mac Grory B; Fakhri H; Brown Espaillat K; Asad SD; Pasupuleti H; Martin H; Tan J; Veerasamy M; Liberman AL; Esenwa C; Cheng N; Moncrieffe K; Moeini-Naghani I; Siddu M; Scher E; Leon Guerrero CR; Khan M; Nouh A; Mistry E; Keyrouz S; Furie K
Ann Neurol; 2020 Oct; 88(4):807-816. PubMed ID: 32656768
[TBL] [Abstract][Full Text] [Related]
37. Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Steinberg BA; Kim S; Thomas L; Fonarow GC; Hylek E; Ansell J; Go AS; Chang P; Kowey P; Gersh BJ; Mahaffey KW; Singer DE; Piccini JP; Peterson ED;
Circulation; 2014 May; 129(20):2005-12. PubMed ID: 24682387
[TBL] [Abstract][Full Text] [Related]
38. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
39. Multicenter Prospective Analysis of Stroke Patients Taking Oral Anticoagulants: The PASTA Registry - Study Design and Characteristics.
Suda S; Iguchi Y; Fujimoto S; Yagita Y; Kono Y; Ueda M; Todo K; Kono T; Mizunari T; Yamazaki M; Kanzawa T; Okubo S; Kondo K; Nakajima N; Inoue T; Iwanaga T; Nakajima M; Imafuku I; Shibazaki K; Mishina M; Adachi K; Nomura K; Nakajima M; Yaguchi H; Okamoto S; Osaki M; Terasawa Y; Nagao T; Kimura K
J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104456. PubMed ID: 31676161
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1.
Coleman CI; Turpie AGG; Bunz TJ; Eriksson D; Sood NA; Baker WL
Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):64-69. PubMed ID: 30020424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
